{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:29:05Z","timestamp":1793806145174,"version":"4.6.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The dysregulation of adenosine triphosphate (ATP) hydrolysis, a crucial process in energy metabolism, has been implicated in the complex landscape of tumor development and progression. This study aims to pinpoint crucial genes that characterize the ATP hydrolysis-driven molecular signature of hepatocellular carcinoma (HCC), with a view to examining their potential therapeutic applications in enhancing patient prognosis. Utilizing transcriptomic and clinical data from The Cancer Genome Atlas and Gene Expression Omnibus databases, a systematic framework was developed and validated for model construction and assessment. Univariate Cox regression analysis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) was performed on all 416 ATP hydrolysis-related genes (ARGs) to identify prognostically relevant genes. Following least absolute shrinkage and selection operator Cox regression with 10-fold cross-validation, an 11-gene signature was established, with the median training cohort risk score used as the cutoff for stratifying patients into high- and low-risk groups. Among 416 investigated ARGs, 85 displayed differential expression in HCC, with 179 demonstrating significant prognostic relevance (univariate Cox\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Two distinct molecular subtypes, characterized by marked differences in prognosis and immune infiltration, were identified through unsupervised clustering. A refined 11-gene signature was constructed via least absolute shrinkage and selection operator Cox regression with 10-fold cross-validation (training area under the curve: 0.826\/0.717\/0.657 for 1\/3\/5 year; validation area under the curve: 0.608\/0.603\/0.621). These risk groups exhibited significantly divergent prognostic features, gene expression patterns, immune microenvironments, and drug sensitivities, suggesting the utility of this risk signature in predicting prognosis, drug responsiveness, and immune therapeutic outcomes. Ultimately, a nomogram incorporating the risk signature was devised, demonstrating favorable predictive performance in estimating HCC patient prognosis compared to other established prognostic factors. This study establishes a classification system and risk model grounded in ARGs, offering valuable insights into the prognosis and treatment responsiveness of HCC.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050860","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:17Z","timestamp":1790359277000},"page":"e50860","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Construction of an ATP hydrolysis-related 11-gene signature for predicting prognosis and immune response in hepatocellular carcinoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Yan","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Digestive Internal Medicine, No. 906 Hospital of the People\u2019s Liberation Army, Ningbo, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1427-262X","authenticated-orcid":false,"given":"Feng","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Digestive Internal Medicine, No. 906 Hospital of the People\u2019s Liberation Army, Ningbo, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options.","volume":"76","author":"Foerster","year":"2022","journal-title":"J Hepatol"},{"key":"R3-20261104","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification.","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted therapy for hepatocellular carcinoma.","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1038\/s41467-023-39742-5","article-title":"Mechanism of ATP hydrolysis dependent rotation of bacterial ATP synthase.","volume":"14","author":"Nakano","year":"2023","journal-title":"Nat Commun"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41557-024-01466-4","article-title":"ATP hydrolysis captured in atomic detail.","volume":"16","author":"Elghobashi-Meinhardt","year":"2024","journal-title":"Nat Chem"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.3390\/molecules25194572","article-title":"ATP-binding and hydrolysis in inflammasome activation.","volume":"25","author":"Sandall","year":"2020","journal-title":"Molecules"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.trecan.2021.04.008","article-title":"Extracellular ATP and adenosine in cancer pathogenesis and treatment.","volume":"7","author":"Chiarella","year":"2021","journal-title":"Trends Cancer"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.7150\/ijbs.35563","article-title":"GATA binding protein 3 boosts extracellular ATP hydrolysis and inhibits metastasis of breast cancer by up-regulating ectonucleoside triphosphate diphosphohydrolase 3.","volume":"15","author":"Li","year":"2019","journal-title":"Int J Biol Sci"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2022.02.062","article-title":"Inhibition of ATP hydrolysis as a key regulator of temozolomide resistance and migratory phenotype of glioblastoma cells.","volume":"601","author":"Scheffel","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jebm.12434","article-title":"ATP-binding cassette (ABC) transporters in cancer: a review of recent updates.","volume":"14","author":"Wang","year":"2021","journal-title":"J Evid Based Med"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures.","volume":"12","author":"Zeng","year":"2021","journal-title":"Front Immunol"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels.","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance.","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"R16-20261104","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data.","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HEP.0000000000000553","article-title":"Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10020-022-00445-0","article-title":"The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.","volume":"28","author":"Deng","year":"2022","journal-title":"Mol Med"},{"key":"R19-20261104","first-page":"1118","article-title":"Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.","volume":"53","author":"Zhang","year":"2018","journal-title":"Int J Oncol"},{"key":"R20-20261104","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/bbb\/zbab154","article-title":"Kinesin family member 2C promotes hepatocellular carcinoma growth and metastasis via activating MEK\/ERK pathway.","volume":"85","author":"Ding","year":"2021","journal-title":"Biosci Biotechnol Biochem"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10408363.2024.2309933","article-title":"KIF2C\/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.","volume":"61","author":"Kreis","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.2147\/CMAR.S176147","article-title":"Upregulation of KIF20A correlates with poor prognosis in gastric cancer.","volume":"10","author":"Sheng","year":"2018","journal-title":"Cancer Manag Res"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fmolb.2020.00060","article-title":"Heat shock protein 60 in hepatocellular carcinoma: insights and perspectives.","volume":"7","author":"Hoter","year":"2020","journal-title":"Front Mol Biosci"},{"key":"R24-20261104","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0024-3205(02)01962-8","article-title":"Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway.","volume":"71","author":"Lee","year":"2002","journal-title":"Life Sci"},{"key":"R25-20261104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12935-016-0332-3","article-title":"Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma.","volume":"16","author":"Qian","year":"2016","journal-title":"Cancer Cell Int"},{"key":"R26-20261104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2015.12.029","article-title":"Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.","volume":"372","author":"Zhang","year":"2016","journal-title":"Cancer Lett"},{"key":"R27-20261104","doi-asserted-by":"crossref","first-page":"e108130","DOI":"10.15252\/embj.2021108130","article-title":"ATP and cancer immunosurveillance.","volume":"40","author":"Kepp","year":"2021","journal-title":"EMBO J"},{"key":"R28-20261104","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3389\/fimmu.2018.02581","article-title":"ATP and its metabolite adenosine as regulators of dendritic cell activity.","volume":"9","author":"Silva-Vilches","year":"2018","journal-title":"Front Immunol"},{"key":"R29-20261104","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.gendis.2022.11.003","article-title":"PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain.","volume":"10","author":"Li","year":"2023","journal-title":"Genes Dis"},{"key":"R30-20261104","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer.","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R31-20261104","doi-asserted-by":"crossref","first-page":"e000610","DOI":"10.1136\/jitc-2020-000610","article-title":"Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.","volume":"8","author":"Yang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"R32-20261104","doi-asserted-by":"crossref","first-page":"121503","DOI":"10.1016\/j.biomaterials.2022.121503","article-title":"ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy.","volume":"284","author":"Yu","year":"2022","journal-title":"Biomaterials"},{"key":"R33-20261104","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation.","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"R34-20261104","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance.","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat Commun"},{"key":"R35-20261104","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: structure, function and regulation.","volume":"16","author":"Du","year":"2018","journal-title":"Nat Rev Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:23Z","timestamp":1793804543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":35,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050860","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2024-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}